METROPOLITAN LIFE INSURANCE CO/NY - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$13,191
-39.1%
4,2010.0%0.00%0.0%
Q2 2023$21,677
-2.1%
4,2010.0%0.00%0.0%
Q1 2023$22,139
+68.9%
4,201
-10.0%
0.00%0.0%
Q4 2022$13,111
-32.3%
4,6660.0%0.00%0.0%
Q3 2022$19,364
+98.8%
4,666
+92.6%
0.00%
Q2 2022$9,740
-61.0%
2,423
-52.0%
0.00%
-100.0%
Q1 2022$24,988
-80.8%
5,048
-73.0%
0.00%
-50.0%
Q4 2021$130,367
-34.8%
18,704
-6.5%
0.00%
-33.3%
Q3 2021$200,040
-29.5%
20,0040.0%0.00%
-25.0%
Q2 2021$283,657
-3.8%
20,004
+11.3%
0.00%0.0%
Q1 2021$295,003
-24.2%
17,977
-4.4%
0.00%
-33.3%
Q4 2020$389,181
+172.0%
18,8010.0%0.01%
+100.0%
Q3 2020$143,076
+12.6%
18,801
+23.3%
0.00%
+50.0%
Q2 2020$127,033
+72.9%
15,250
+2.7%
0.00%0.0%
Q1 2020$73,468
-99.9%
14,842
+21.1%
0.00%
+100.0%
Q2 2018$82,749,000
+51943.4%
12,259
-28.5%
0.00%0.0%
Q2 2017$159,000
+14.4%
17,157
+73.5%
0.00%0.0%
Q3 2015$139,000
-33.2%
9,8870.0%0.00%0.0%
Q2 2015$208,0009,8870.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders